This finding is important because Dialysis Related Amyloidosis (DRA) is probably the only amyloid disease in which we can exactly establish the time (the first day of haemodialysis) in which a pro-amyloidogenic phase is triggered by simply increasing the concentration of plasma β2-m. Here, B2M is linked to amyloidosis.